Neuroelectrics Analysis

Personalized brain stimulation therapy for brain disorders

Treat epilepsy with targeted brain stimulation; Monitor brain activity using advanced EEG technology; Provide at-home neuromodulation therapy for depression; Conduct research on brain disorders using proprietary tools; Develop personalized treatment plans based on neuroscience data.

Participated in pivotal trials for refractory focal epilepsy; Technologies used in numerous published scientific papers; Focus on non-invasive treatment options for brain disorders.

Main Information

• Information: Neuroelectrics pioneers brain stimulation and AI-based therapies for neurological diseases. They provide non-invasive, high-definition technology for personalized neuromodulation to restore brain health and improve lives. Founded in 2011 and based in Barcelona and Boston, Neuroelectrics distributes products in over 70 countries for neuroscience and clinical research. Their neurotechnology platform supports clinical applications to diagnose and treat brain diseases, including epilepsy, neuropathic pain, and mood disorders, as well as cognitive enhancement in dementia and ADHD. By measuring and modifying brain activity, they develop innovative solutions to enhance cognitive function and overall well-being.
• Interests: Artificial Intelligence, Health/Fitness/Wellbeing
• Location: Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B12
• Whether tagged as startup: Not a Startup

Contact & Links

• LinkedIn: Connect on LinkedIn
• Twitter: No relevant data.
• Phone Number: No relevant data.
• Email: No relevant data.

Key Information

• Growth Stage: Not a Startup
• Country: Spain
• Founding Year: 2011

Company Context

• Company Name: Neuroelectrics
• Company Website: Neuroelectrics Website